Yes , lets not forget how many different way Leron

Yes , lets not forget how many different way Leronlimab is working ,
I believe , there is a very good chance that most of good candidates , will respond well , and medicine will work for a long time..

Lets not forget that chemotherapy will work better also with Leronlimab, and there will be no resistance to it forming , same as check point inhibitors , with Leronlimab patients should have less chance to develop those very serious side effects , and less chance to develop resistance.

All together I am not sure if we will need to combine with check point inhibitors , I have a feeling that in the future they will do study to see if medicine is working better together or Leronlimab doing good job alone , since they also working similarly on check points.

And Dr Lindner observed doing our pre-clinical study for mColon cancer that Leronlimab inhibits angiogeneses , Dr Patterson commented once that they see 60-70% less of those new blood vessels forming around the tumors .
And is working on solid tumors with both high and low CCR5 expression ..

Right now another drug is often added to chemotherapy , Avastin to have this effect...


Our medicine is amazing , and so far without one serious side effect . .




IMO as always.